MYOTONIC DYSTROPHY TYPE 1

Clinical trials for MYOTONIC DYSTROPHY TYPE 1 explained in plain language.

Never miss a new study

Get alerted when new MYOTONIC DYSTROPHY TYPE 1 trials appear

Sign up with your email to follow new studies for MYOTONIC DYSTROPHY TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet finished but already full! 1

Four-Year trial tests potential new treatment for debilitating muscle disease

Disease control ENROLLING_BY_INVITATION

This study is testing the long-term safety and effectiveness of an investigational drug called del-desiran for adults with myotonic dystrophy type 1 (DM1), a genetic muscle-wasting disease. Participants who completed a previous related study will receive an intravenous infusion o…

Matched conditions: MYOTONIC DYSTROPHY TYPE 1

Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

MYOTONIC DYSTROPHY TYPE 1

Get alerted when new MYOTONIC DYSTROPHY TYPE 1 trials appear

Four-Year trial tests potential new treatment for debilitating muscle disease